ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,473.23
      0.77%
      US Tech 100
      19,430.00
      0.14%
      Dow Jones
      38,778.10
      0.49%
      Brent Oil
      83.75
      -0.18%
      Bitcoin
      65,240.48
      -1.87%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Moleculin Biotech Inc (MBRX)

      7. Moleculin Biotech Inc (MBRX) News

      MBRX Moleculin Biotech Inc

      3.94
      0.00 (0.00%)
      Pre Market
      Last Updated: 07:07:40
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Moleculin Biotech Inc MBRX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 3.94 07:07:40
      Open Price Low Price High Price Close Price Prev Close
      3.94
      more quote information »

      Recent News

      Date Time Source Heading
      6/14/202408:00EDGAR2Form 8-K - Current report
      6/14/202408:00PRNUSMoleculin Announces Additional Positive Preliminary Interim..
      6/12/202409:00PRNUSMoleculin to Present at the Virtual Investor Pitch..
      6/07/202417:05EDGAR2Form S-3 - Registration statement under Securities Act of..
      6/05/202408:55PRNUSMoleculin to Participate in the Virtual Investor Lunch Break..
      5/16/202408:32EDGAR2Form 8-K - Current report
      5/16/202408:32PRNUSMoleculin Abstract Accepted for Poster Presentation at the..
      5/15/202408:38EDGAR2Form 8-K - Current report
      5/15/202408:38PRNUSMoleculin Announces Commencement of NIH-Funded Phase 2..
      5/14/202416:16EDGAR2Form 8-K - Current report
      5/13/202410:53EDGAR2Form 8-K/A - Current report: [Amend]
      5/13/202407:30EDGAR2Form 8-K - Current report
      5/13/202407:30PRNUSMoleculin Reports First Quarter 2024 Financial Results and..
      5/10/202416:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      5/09/202408:30EDGAR2Form 8-K - Current report
      5/09/202408:30PRNUSMoleculin Announces U.S. Patent Issue Notification for..
      5/08/202408:45PRNUSMoleculin to Report First Quarter 2024 Financial Results on..
      5/08/202408:31EDGAR2Form 8-K - Current report
      5/07/202416:13EDGAR2Form 8-K - Current report
      5/07/202408:55EDGAR2Form 8-K - Current report
      5/07/202408:55PRNUSMoleculin Reports Higher AML Complete Remission (CR) Rates..
      5/02/202409:00PRNUSMoleculin to Host Virtual AML Clinical Day Featuring..
      5/01/202408:50PRNUSMoleculin Announces Formation of Scientific Advisory Board..
      4/18/202408:30PRNUSEuropean Medicines Agency (EMA) Grants Orphan Drug..
      4/10/202408:30PRNUSMoleculin Announces Presentation of Positive Data..
      3/28/202410:45PRNUSMoleculin to Present at the MedInvest Biotech & Pharma..
      3/27/202409:25PRNUSMoleculin to Participate in the Virtual Investor Lunch..
      3/27/202409:05PRNUSMoleculin Announces U.S. Patent Issue Notification for..
      3/25/202407:30PRNUSMoleculin Announces Positive Interim Data in Annamycin..
      3/22/202416:05PRNUSMoleculin Reports Full Year 2023 Financial Results
      3/20/202407:30PRNUSMoleculin to Report Full Year 2023 Financial Results on..
      3/20/202407:15IHMARKETNEWSJPMorgan boosts dividends, Chipotle unveils 50:1 stock..
      3/19/202416:30PRNUSMoleculin Announces Reverse Stock Split
      3/12/202409:05PRNUSMoleculin to Present at the 36th Annual ROTH Conference
      2/29/202408:30EDGAR2Form 8-K - Current report
      2/22/202409:30EDGAR2Form 8-K - Current report
      2/16/202417:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      2/15/202409:15EDGAR2Form 8-K - Current report
      2/14/202416:36EDGAR2Form 8-K - Current report
      2/14/202416:33EDGAR2Form 8-K - Current report
      2/13/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
      2/02/202417:05EDGAR2Form S-1 - General form for registration of securities under..
      1/24/202408:50EDGAR2Form 8-K - Current report
      1/24/202408:50PRNUSMoleculin Announces 2023 Year-End Annamycin Clinical Trials..
      1/16/202417:00EDGAR2Form DEF 14A - Other definitive proxy statements
      1/05/202417:15EDGAR2Form PRE 14A - Other preliminary proxy statements
      1/05/202417:14EDGAR2Form 8-K - Current report
      12/27/202307:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/22/202317:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      12/21/202317:17EDGAR2Form 8-K - Current report

      Your Recent History

      NASDAQ
      MBRX
      Moleculin Biotech
      TG
      V1L
      Valero Energy
      USOTC
      TMPWQ
      Tempo Automation (CE)
      Delayed Upgrade Clock